Taxol Boosts Odds of Chronic Pain - US News and World Report
Links shared publicly online about this topic.
- 1,563total visits
Taxol Boosts Odds of Chronic Pain - US News and World Report
MONDAY, Nov. 30 (HealthDay News) -- The chemotherapy drug paclitaxel (Taxol) increases the risk of chronic neuropathic pain in breast cancer survivors, a new study shows. It included 240 women who took part in clinical trials of Taxol between 1994 and 2001. Those who experienced chemotherapy-induced peripheral neuropathy during their treatment with Taxol were three times more likely to eventually be diagnosed with chronic neuropathic pain.
View full resource at health.usnews.com
Tags: Cancer Medication, Chemotherapy, Breast Cancer, Neuropathic Pain, Drug, Clinical Trial, Women's Health, Taxol
Most Recently Shared on December 1, 2009 at 3:25 am By:
"Taxol Boosts Odds of Chronic Pain - Breast cancer patients getting the drug may suffer long-term neuropathic ..." http://hub.tm/?qtKHL
Advertisement
